Verisk Analytics (VRSK) Valuation Check After Zen Insurance Launch And Recent AI Partnerships

Verisk Analytics, Inc.

Verisk Analytics, Inc.

VRSK

0.00

Verisk Analytics (VRSK) is back in focus after Zen Insurance officially launched in the UK as a fully digital car insurer, built on Verisk Ignite and Applied Systems Europe’s connectivity tools.

The Zen Insurance launch and Verisk’s recent AI partnerships come at a time when the stock’s 1-day share price return of 3.64% contrasts with a year-to-date share price decline of 26.45% and a 1-year total shareholder return decline of 47.08%. This suggests recent enthusiasm is emerging against a weak longer-term backdrop.

If you are looking beyond Verisk and this insurance-focused rollout, it could be a good moment to see what other AI-driven companies are doing by checking out 62 profitable AI stocks that aren't just burning cash

With Verisk trading at a 33% intrinsic discount and about 37% below analyst price targets, the key question is whether this reset leaves meaningful upside on the table or if the market already reflects its future growth.

Most Popular Narrative: 133.2% Overvalued

Against a last close of $162.55, the most followed narrative pegs Verisk’s fair value at $69.70, which implies a steep valuation gap that challenges the recent share price rebound.

Verisk Analytics is a regulatory-grade data toll on the US property & casualty insurance industry, monetized through ~83% subscription revenue with ~92% client retention. VRSK's narrow-moat franchise produces FCF with an unusually high degree of predictability, durable enough to justify a 15× exit multiple at a 35% margin of safety. The 2022 to 2025 portfolio simplification (Energy, Argus, 3E, Marketing Solutions all divested) has produced a cleaner pure-play with structurally higher margins (Adj EBITDA 56.2% in 2025 vs. 53.5% in 2023) and a shrinking share count (~19% reduction since 2019). What the investor is paying for here is a regulatory annuity with an embedded MSD price-and-volume escalator, and walking away from any thesis premised on this becoming a HSD to DD revenue compounder.

Want to see how a slow and steady revenue outlook still supports such a low fair value? The narrative leans heavily on rich margins, recurring cash flows and a firm view on what multiple those earnings deserve. The tension between that cash flow quality and the current market price is where the real story sits.

Result: Fair Value of $69.70 (OVERVALUED)

However, steady subscription revenue and client retention could face pressure if insurance customers reduce data spending or if regulators change how Verisk’s tools can be used.

Another View: What The Ratios Are Saying

That user narrative calls Verisk overvalued, yet the share price of $162.55 sits 33.1% below an internal fair value estimate and trades on a 23.4x P/E versus a 24.4x fair ratio. Peers average 28.3x while the wider Professional Services industry sits at 18.4x. With that mix of cheaper than peers but richer than the industry, how should you weigh the valuation risk here?

NasdaqGS:VRSK P/E Ratio as at May 2026
NasdaqGS:VRSK P/E Ratio as at May 2026

Next Steps

Reading mixed signals on Verisk’s story so far? Take a closer look at the numbers, weigh the concerns and potential upsides, and then check out 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Verisk has you thinking differently about risk, do not stop here. Broaden your watchlist with other angles that could sharpen your next move.

  • Target stability and income by checking companies in the 12 dividend fortresses that may support long-term cash flow goals.
  • Hunt for quality at a discount by reviewing the 50 high quality undervalued stocks that combine fundamentals with more modest pricing.
  • Prioritise resilience by scanning the 66 resilient stocks with low risk scores that score well on financial strength and lower risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.